The SARS-CoV-2 Spike protein is often the main target of COVID-19 therapeutic research efforts. Yet, numerous other structural and non-structural proteins (NSPs) comprise the SARS-CoV-2 virus. A greater understanding of coronavirus-related antigens is critical for optimizing the research, development, and manufacturing of novel therapeutics and robust diagnostics. In this webinar sponsored by R&D Systems, part of the Bio-Techne Corporation, Anthony Person will discuss novel protein-based assays for COVID-19 and how they can advance diagnostic and therapeutic development.
Topics to be covered
Speaker Information:
Anthony Person, PhD
Sr. Director, Protein Business Unit
Bio-Techne
Interested in sponsoring a webinar?
Click here to contact our friendly sales team.
Drug Discovery News
1000 N West Street | Wilmington | Delaware | 19801 | US
Email: privacy@drugdiscoverynews.com
© 2021 Old River Publications LLC. All rights reserved
Drug Discovery News needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy